Glirio M (Glimperide (8mg)+ Metformin hydrochloride (850mg)

Glirio M is a potent combination therapy that features Glimepiride (8 mg) and Metformin hydrochloride (850 mg) designed for the effective management of type 2 diabetes mellitus. Glimepiride stimulates insulin secretion from the pancreas aiding in the reduction of blood sugar levels while Metformin enhances insulin sensitivity and decreases glucose production by the liver. This dual-action formulation helps achieve better glycemic control and reduces the risk of complications associated with diabetes making Glirio M an excellent option for patients seeking comprehensive diabetes management.